Literature DB >> 22118039

Serologic evidence of human leptospirosis in and around Kolkata, India: a clinico-epidemiological study.

Manisha DebMandal1, Shyamapada Mandal, Nishith Kumar Pal.   

Abstract

OBJECTIVE: To investigate the prevalence of leptospirosis among patients from within and outside Kolkata, India, attending the Calcutta School of Tropical Medicine, for treatment during August 2002 to August 2008.
METHODS: The leptospirosis cases were determined on the basis of clinical, epidemiological, and biochemical factors, and were tested for leptospiral antibodies using IgM ELISA. Serum samples with absorbance ratio ≥ 1.21 were interpreted as reactive.
RESULTS: The commonest presentation involved fever, headache and jaundice. The male-female ratio was 61:46. A total of 65(64.20%) cases had abnormal liver and renal functions respectively, and 57.1% had both the abnormalities. The highest incidence (75, 35.04%) was recorded in September-October followed by July-August (53, 24.77%). The reactive cases had absorbance ratios between 1.21 and 8.21, and 53 showed equivocal result, while IgM non reactivity were seen in 90 patients (absorbance ratios 0.10-0.90). The patients responded to treatment with parenteral antibiotics, penicillin, ceftriaxone and cefotaxime; follow up did not reveal case fatality.
CONCLUSIONS: The cardinal signs of leptospirosis help in making clinical diagnosis, but in any hyper-endemic situation any patient reporting with acute fever and signs of pulmonary, hepatic or renal involvement should be suspected to have leptospirosis and investigated accordingly. Increased awareness, and early diagnosis and treatment, can reduce mortality due to leptospirosis.
Copyright © 2011 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118039     DOI: 10.1016/S1995-7645(11)60234-4

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  4 in total

1.  Clinical profile, management and outcome of patients with leptospirosis during the times of COVID-19 pandemic: A prospective study from a tertiary care centre in South India.

Authors:  Nitin Gupta; William Wilson; Prithvishree Ravindra; Sowmya Joylin; Rachana Bhat; Kavitha Saravu
Journal:  Infez Med       Date:  2021-09-10

2.  Utility of Loop-mediated Isothermal Amplification Assay, Polymerase Chain Reaction, and ELISA for Diagnosis of Leptospirosis in South Indian Patients.

Authors:  Mallika Sengupta; Abhilash Kundavaram Paul Prabhakar; Sowmya Satyendra; David Thambu; Ooriapadickal Cherian Abraham; Veeraraghavan Balaji; Hua-Wei Chen; Chien-Chung Chao; Wei-Mei Ching; John Antony Jude Prakash
Journal:  J Glob Infect Dis       Date:  2017 Jan-Mar

3.  Epidemiological determinants of leptospirosis in rural and urban districts of Maharashtra, India.

Authors:  Ravindra S Kembhavi; Gajanan D Velhal; Anuradha K Shah
Journal:  J Family Med Prim Care       Date:  2021-09-30

4.  Evaluation of two immunodiagnostic tests for early rapid diagnosis of leptospirosis in Sri Lanka: a preliminary study.

Authors:  Egwin J Eugene; Shiroma M Handunnetti; Shalini A Wickramasinghe; Thilini L Kalugalage; Chathuraka Rodrigo; Hasith Wickremesinghe; Nandana Dikmadugoda; Pranitha Somaratne; H Janaka De Silva; Senaka Rajapakse
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.